Apol­lo Health Ven­tures pumps an­oth­er $180M in­to the bur­geon­ing race to slow ag­ing

An­ti-ag­ing re­search has pro­gressed rapid­ly over the last sev­er­al years, with Google and even Ama­zon bil­lion­aire Jeff Be­zos buy­ing in. But the field’s lat­est in­vest­ments will come from Apol­lo Health Ven­tures, which has raised $180 mil­lion to fund ear­ly en­trants in the bur­geon­ing race to pro­long hu­man life.

Apol­lo closed its sec­ond fund on Wednes­day, about three years af­ter clos­ing its first fund at some­where north of $20 mil­lion (though that fig­ure could still go up if in­vestors con­tribute to fol­low-on rounds), CFO Steven Le­unert told End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER